These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3345291)

  • 1. Antilymphocyte globulin for myelodysplastic syndrome.
    Tichelli A; Gratwohl A; Wuersch A; Nissen C; Speck B
    Br J Haematol; 1988 Jan; 68(1):139-40. PubMed ID: 3345291
    [No Abstract]   [Full Text] [Related]  

  • 2. A bit of antithymocyte globulin can take you a long way!
    Mohty M
    Bone Marrow Transplant; 2012 May; 47(5):617-8. PubMed ID: 22569034
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical characteristics and treatment outcome in 65 cases with refractory cytopenia of childhood defined according to the WHO 2008 classification.
    Hasegawa D; Chen X; Hirabayashi S; Ishida Y; Watanabe S; Zaike Y; Tsuchida M; Masunaga A; Yoshimi A; Hama A; Kojima S; Ito M; Nakahata T; Manabe A
    Br J Haematol; 2014 Sep; 166(5):758-66. PubMed ID: 24894311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelodysplastic syndrome.
    Nakao S; Deeg HJ; Ishikawa T; Marsh J; List A; Tomonaga M
    Int J Hematol; 2005 Dec; 82(5):412-6. PubMed ID: 16533744
    [No Abstract]   [Full Text] [Related]  

  • 5. Treating patients of myelodysplastic syndrome with antithymocytic globulin--should we be more selective?
    Madkaikar M; Ghosh K
    Blood; 2003 Nov; 102(10):3851-2; author reply 3852. PubMed ID: 14597610
    [No Abstract]   [Full Text] [Related]  

  • 6. Recovery from severe idiopathic aplastic pancytopenia following antithymocyte globulin therapy.
    Ansari A; Grotte M
    Minn Med; 1986 Jun; 69(6):361-4. PubMed ID: 3489162
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunosuppressive therapy for hypoplastic myelodysplastic syndrome.
    Biesma DH; van den Tweel JG; Verdonck LF
    Cancer; 1997 Apr; 79(8):1548-51. PubMed ID: 9118037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Favourable response to splenectomy in familial myelodysplastic syndrome.
    Abdul-Wahab J; Naznin M; Suhaimi A; Amir-Hamzah AR
    Singapore Med J; 2007 Jul; 48(7):e206-8. PubMed ID: 17609817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-thymocyte globulin therapy induced a spurious increase of fibrinogen degradation products in hypoplastic myelodysplastic syndrome.
    Yahata Y; Isobe Y; Sasaki M; Oshimi K; Sugimoto K
    Eur J Haematol; 2009 May; 82(5):404. PubMed ID: 19191866
    [No Abstract]   [Full Text] [Related]  

  • 10. A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes.
    Stadler M; Germing U; Kliche KO; Josten KM; Kuse R; Hofmann WK; Schrezenmeier H; Novotny J; Anders O; Eimermacher H; Verbeek W; Kreipe HH; Heimpel H; Aul C; Ganser A
    Leukemia; 2004 Mar; 18(3):460-5. PubMed ID: 14712285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful immunosuppressive therapy for a child with Myelodysplastic syndrome.
    Orimoto M; Maeda M; Cai LZ; Hayakawa J; Ueda T; Migita M; Asano T
    Med Pediatr Oncol; 2003 May; 40(5):334-5. PubMed ID: 12652627
    [No Abstract]   [Full Text] [Related]  

  • 12. [Outcome of immunosuppressive therapy for myelodysplastic syndromes: results of 12 cases from a single institution].
    Miyata A; Yasuda Y; Fujii S; Kikuchi T
    Rinsho Ketsueki; 2002 Oct; 43(10):911-7. PubMed ID: 12462026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Favourable response to antithymocyte globulin therapy in resistant acute graft-versus-host disease.
    Tagliabue A; Corti P; Viganò E; Bonanomi S; Uderzo C
    Bone Marrow Transplant; 2005 Sep; 36(5):459. PubMed ID: 15980883
    [No Abstract]   [Full Text] [Related]  

  • 14. Antithymocyte globulin for a patient with systemic lupus erythematosus complicated by severe pancytopenia.
    Morishita Y; Matsukawa Y; Kura Y; Takei M; Tomita Y; Nishinarita S; Horie T
    J Int Med Res; 1997; 25(4):219-23. PubMed ID: 9283997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Myelodysplastic syndrome].
    Urabe A
    Gan To Kagaku Ryoho; 2005 Mar; 32(3):287-91. PubMed ID: 15791810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematologic responses of patients with MDS to antithymocyte globulin plus etanercept correlate with improved flow scores of marrow cells.
    Deeg HJ; Jiang PY; Holmberg LA; Scott B; Petersdorf EW; Appelbaum FR
    Leuk Res; 2004 Nov; 28(11):1177-80. PubMed ID: 15380342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithymocyte globulin before allogeneic stem cell transplantation for progressive myelodysplastic syndrome: a study from the French Society of Bone Marrow Transplantation and Cellular Therapy.
    Duléry R; Mohty M; Duhamel A; Robin M; Beguin Y; Michallet M; Vigouroux S; Lioure B; Garnier A; El Cheikh J; Bulabois CE; Huynh A; Bay JO; Daguindau E; Ceballos P; Clément L; Dauriac C; Maillard N; Legrand F; Cornillon J; Guillerm G; François S; Lapusan S; Chevallier P; Damaj G; Yakoub-Agha I
    Biol Blood Marrow Transplant; 2014 May; 20(5):646-54. PubMed ID: 24462982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Polyclonal rabbit antithymocyte globulin (thymoglobulin): immunomodulatory effects and new aspects of its clinical application].
    Kulagin AD; Lisukov IA; Miloserdov IA; Afanas'ev BV
    Ter Arkh; 2010; 82(7):65-72. PubMed ID: 20853613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of myelodysplastic syndromes.
    Stadler M; Ganser A
    N Engl J Med; 2005 May; 352(20):2134-5; author reply 2134-5. PubMed ID: 15906434
    [No Abstract]   [Full Text] [Related]  

  • 20. Determining which patients with myelodysplastic syndrome will respond to immunosuppressive treatment.
    Barrett J; Sloand E; Young N
    Haematologica; 2006 May; 91(5):583-4. PubMed ID: 16670061
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.